Drug Shortage Report for TROMBOJECT 3%
Report ID | 206243 |
Drug Identification Number | 00511226 |
Brand name | TROMBOJECT 3% |
Common or Proper name | Sodium Tetradecyl Sulfate Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM TETRADECYL SULFATE |
Strength(s) | 30MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 x 5mL vial / fiole |
ATC code | C05BB |
ATC description | ANTIVARICOSE THERAPY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-01 |
Estimated end date | |
Actual end date | 2024-02-07 |
Shortage status | Resolved |
Updated date | 2024-02-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-10-04 | English | Compare |
v2 | 2023-10-04 | French | Compare |
v3 | 2023-12-05 | English | Compare |
v4 | 2023-12-05 | French | Compare |
v5 | 2023-12-19 | English | Compare |
v6 | 2023-12-19 | French | Compare |
v7 | 2024-02-06 | English | Compare |
v8 | 2024-02-06 | French | Compare |
v9 | 2024-02-08 | English | Compare |
Showing 1 to 9 of 9